ARTICLE | Distillery Therapeutics

Therapeutics: Plasmodium sporozoite asparagine-rich protein (SLARP); P. falciparum circumsporozoite protein B9 (B9; CSP)

January 15, 2015 8:00 AM UTC

In vitro and mouse studies suggest a genetically attenuated parasite could be used to vaccinate against malaria. Plasmodium berghei with engineered deletions of the B9 and SLARP genes - which are requ...